BIODESIX INC — Director's Dealing 2020

Oct 28, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-10-27

Reporting Person: Franchi Jean M. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$6.83	2030-03-31	Common Stock (29364)		Direct
Restricted Stock Units	$6.83	2030-03-31	Common Stock (26368)		Direct

Footnotes

F1: This option vests in 12 successive, equal monthly installments measured from April 1, 2020.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer Common Stock ("Common Stock"). These RSUs vest 40% on April 1, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from April 1, 2022.